论文部分内容阅读
目的探讨三磷酸腺苷(ATP)与普罗帕酮转复阵发性室上性心动过速的临床疗效。方法将2008年3月至2010年4月到我院急诊科就诊的阵发性室上性心动过速患者80例随机分为ATP组和普罗帕酮组,每组各40例患者。观察二者的临床疗效。结果 ATP组有效率90,平均转复时间(5.91±2.4)min,不良反应发生率7.5;普罗帕酮组有效率87.5,平均转复时间(8.93±2.6)min,不良反应发生率15,两药平均转复时间、不良反应发生率差异有统计学意义(P<0.05)。结论 ATP治疗阵发性室上性心动过速与普罗帕酮转复成功率相似,但不良反应少,起效更快。
Objective To investigate the clinical efficacy of adenosine triphosphate (ATP) and propafenone in the treatment of paroxysmal supraventricular tachycardia. Methods Eighty patients with paroxysmal supraventricular tachycardia who visited our emergency department from March 2008 to April 2010 were randomly divided into ATP group and propafenone group, 40 cases in each group. Observe the clinical efficacy of both. Results The effective rate of ATP group was 90, the average recovery time was 5.91 ± 2.4 min, and the incidence of adverse reactions was 7.5. The effective rate of propafenone group was 87.5, the average recovery time was 8.93 ± 2.6 min, the incidence of adverse reactions was 15, The mean recovery time and the incidence of adverse reactions were statistically significant (P <0.05). Conclusions The success rate of ATP therapy for paroxysmal supraventricular tachycardia is similar to that of propafenone, but it has fewer side effects and faster onset of action.